"Enspectra Health...has been awarded $2M in grant funding from the National Cancer Institute (NCI), part of the National Institutes of Health, through the Small Business Innovation Research (SBIR) Program. The funding will support research for developing deep learning algorithms to predict which precancerous lesions, Actinic Keratosis (AK), are likely to progress to squamous cell carcinoma (SCC), a form of non-melanoma skin cancer."